We report a case of endocarditis associated with a highly gentamicin-resistant enterococcus that failed to respond to conventional antibiotic combination therapy. Clinical resolution was achieved following cardiac surgery and antimicrobial treatment dictated by in vitro testing of the patient's organism. Laboratories should test blood culture isolates of enterococci for high level gentamicin resistance. Management of such cases requires individual assessment and extensive laboratory investigation.
Introduction
The established antibiotic regimen for the treatment of enterococcal endocarditis is penicillin (or vancomycin in the presence of B-lactam allergy) given with an aminoglycoside. Faecal streptococci may show tolerance to the action ofpenicillin or vancomycin but the synergistic combination of either of these with an aminoglycoside provides an effective therapeutic option. We report a case of endocarditis due to a highly gentamicin-resistant enterococcus and discuss the resultant problems in achieving adequate antimicrobial therapy.
Case report
A 69 year old man underwent transurethral resection of the prostate for an adenocarcinoma in another hospital. Because of known aortic and mitral valve disease he was given cephradine (500 mg 6 hourly for 18 hours) perioperatively. This was followed by radiotherapy and over the following 3 months he received 3 courses of antibiotics for recurrent urinary tract infections.
Four months after operation he was admitted in severe cardiac failure which responded to bed rest and diuresis. He was afebrile and otherwise well. Echocardiography confirmed regurgitation of the aortic and mitral valves but also detected vegetations on the aortic valve.
Six sets of blood cultures drawn over a 3-day period all grew a faecal streptococcus. Following the diagnosis of infective endocarditis, therapy was initiated with benzyl penicillin (2 mega-units every 4 hours) and gentamicin (dosage determined by serum levels) both given intravenously. Despite the patient's improved clinical condition, in vitro tests of his serum bactericidal levels proved unfavourable. Blood cultures taken after 7 days of antibiotic treatment grew the faecal streptococcus once again. After extensive bacteriological testing, therapy was changed to a combination of intravenous ampicillin 2 g four hourly and ciprofloxacin 200 mg twice daily. Seven days later, the diseased aortic valve was removed at operation because of gross haemodynamic decompensation. At surgery, vegetations were noted on the left and non-coronary cusp and there was a large perforation in the centre of the non-coronary cusp. There was no evidence of an aortic root abscess and the mitral valve appeared normal. A Carpentier-Edwards valve was inserted.
A faecal streptococcus was grown from culture of the aortic vegetations. Antibiotic therapy continued for a further 5 weeks. The patient remained well on review 3 months later.
Bacteriological methods
The patient's blood was cultured in thioglycolate broth and by means of a modified Castenada biphasic medium. Subcultures on cysteine and heated blood ('chocolate') agar were incubated anaerobically and in an atmosphere of 5% carbon dioxide in air respectively. Material taken from the aortic vegetations was inoculated on to blood, chocolate and MacConkey agar which were incubated aerobically and in an atmosphere of 5% carbon dioxide in air. Anaerobic cultures were performed on blood agar containing neomycin (70 mg/I) and cysteine (0.05%) as well as on blood agar containing cysteine alone. was noted on determination of the MICs of ampicillin and penicillin, i.e., the killing effect of penicillin or ampicillin was maximum at about the MIC and decreased as the concentration of the B-lactam was increased. The clinical significance of these findings is uncertain. The addition of gentamicin at various concentrations did not achieve synergy. Characteristically, enterococci are tolerant to vancomycin2022 and our organism fulfilled these criteria. The addition of gentamicin did not provide a synergistic combination. 23 Careful synergy testing by a variety of techniques did not provide a reliably bactericidal combination against this organism. Laboratory testing revealed a MIC of I fig/ml for ciprofloxacin and stasis was achieved on synergy testing with ampicillin and ciprofloxacin. Grimm24 described a synergistic bactericidal effect when ampicillin and ciprofloxacin are used against enterococci in combination. In our patient, 48 hours after starting ciprofloxacin and ampicillin, blood cultures became negative, serum static levels were more acceptable and, following surgery, the patient improved markedly and remained well 3 months after treatment was completed.
This case illustrates the significant role the laboratory can play in the management of serious infection. It was the positive blood cultures and poor serum bactericidal levels which precipitated the change in treatment and contributed to the decision to operate.
In conclusion, high level resistance to gentamicin in enterococci is already well established in the USA and elsewhere and is likely to become more common in the United Kingdom. When enterococci are isolated from blood cultures it is recommended that they be tested with a high content gentamicin disc (or an MIC performed)25 It may be prudent to barrier nurse cases as they arise' and to consider the value of early surgery. The choice of appropriate antibiotics is difficult and we suggest each case be assessed individually and bactericidal antibiotics used if possible. There is great need for new antibiotics with activity against such organisms.
